9-Me-BC
| 製品名 | 9-Me-BC |
|---|---|
| CAS番号 | 2521-07-5 |
| 分子式 | C10H12N2 |
| 分子量 | 160.22 g/mol |
| 外観 | Off-white to pale yellow crystalline powder |
| 分析(HPLC) | ≥98.0% |
| 融点 | 118–122 °C |
| 溶解度 | Soluble in DMSO, ethanol; slightly soluble in water |
| パッケージ | 1 kg, 5 kg, 25 kg fiber drums |
お困りですか? 弊社チームまでお問い合わせください

Synonyms: 9-Methyl-β-carboline, 9-Me-BC, 9-Methyl-9H-pyrido[3,4-b]indole, 9-Methylnorharman, 9-Methyl-β-carboline
9-Me-BC is a synthetic methylated β-carboline derivative that has become a molecule of interest in neuropharmacology and medicinal chemistry research. Unlike many β-carbolines isolated from natural sources, 9-Me-BC is produced through controlled chemical synthesis, allowing for high purity and consistent supply. Its structure features a methyl group at the indole nitrogen, a modification that significantly influences its interaction with monoamine systems and its metabolic stability compared to norharman and harman.
In the research community, 9-Me-BC is primarily investigated for its potential effects on dopaminergic neurons and neurotrophic signaling. Preclinical studies suggest it may upregulate tyrosine hydroxylase and promote neurite outgrowth, making it a valuable tool for studying Parkinson’s disease models and dopamine-related pathways. Its ability to cross the blood-brain barrier and its relatively favorable pharmacokinetic profile in animal models have further fueled interest.
While not approved for human use, 9-Me-BC is supplied as a reference standard and research chemical for in vitro and in vivo studies. It is available at high purity, typically ≥98% by HPLC, and is characterized by NMR and mass spectrometry to ensure structural integrity. Researchers value it for its selectivity and the reproducibility it brings to neurobiological experiments.
| パラメータ | 仕様 |
|---|---|
| 分析(HPLC) | ≥98.0% |
| 識別 | Conforms to structure |
| 乾燥減量 | ≤0.5% |
| 焼失残渣 | ≤0.11 TP3T |
| 重金属 | 10 ppm以下 |
| Microbial Limits | Total aerobic count ≤1000 CFU/g |